ABSTRACT Highly purified peripheral T.lymphocytes do not proliferate.in response to phytohenagglutinin A or concanavalin A, unless adherent.HLA-DR' monocytes are added as aceessory cells. The accessory function (AF) of monocytes is mediated through the release of interleukin-l (IL-1). We here report that cells from three human leukemic lines-K562, HL-60, and U?937-could exert AF and efficiently-replace monocytes in a 72-hr mitogen-stimulated proliferation assay. This AF was clearly related.to precise maturational4stages of these cells, since the hematopoietic precursor K562. cells spontaneously exerted high AF but lost this property when treated with differentiation inducers 'such as sodium butyrate-or phorbol 12-myristate 13-acetate (PMA). On the other hand, untreated HL-60 and U+937 cells exhibited no spontaneous AF, but theyacquired this function when induced to differentiate either along the granulocytic pathway (dimethyl sulfoxide-treated HL-60 cells) or along the monocytic pathway (PMAtreated HL-60. and U-937 cells). Supernatants-from PMA-triggered K562 or HL-60 cells allowed the proliferative 'response of murine thymocytes to phytohemagglutinin A and'were therefore shown to contain IL-1. Analysis of phenotypical markers showed that AF and IL-I production were not restricted to cells of the monocytic lineage. No HLA-DR antigen could be detected on K562 and HL-60 cells. Thus, the expression of HLA-DR antigens is not required for AF and IL-I production inresponse to mitogens. Human leukemia cell lines could provide usefulsources of human IL-1.
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T-cell activation-by antigen or mitogen is dependent upon the development of cellular cooperations and the'production of regulatory molecules such as interleukins. The T-cell activation pathway, in mice and' men, involves a complex cascade of cellular events; thus highly purified T lymphocytes do not exhibit any proliferative response to mitogens such as phytohemagglutinin A (PHA) or concanavalin' A (Con A) in the absence of other cells exerting the so-called "accessory activity." Within purified blood mononuclear. cells, monocytes are considered to play the major role in this accessory function (AF) (1). Several authors have demonstrated that this function was mediated through the release of interleukin 1 (IL-1), a factor acting as a second signal with antigens or mitogens on T cells (2, 3) . Accessory cells (AC) were shown to express Ia antigens (4) in mice and HLA-DR antigens in humans (5) . The actual role of these antigens in AF remains controversial (6, 7) .
The murine-monocytic leukemia cell line P388D1 was shown to exert AF (8) and'to produce high amounts of IL-1, allowing its biochemical characterization (9) . In humans, IL-1 production by some monocytic-leukemia cells has also been reported (10) . 
MATERIALS-AND METHODS
-Cell'Lines. K562 is a human leukemic-cell line derived from the-pleural effusion of a patient with chronic myelogenous leukemia in terminal-blast crisis (11) . HL-60 is a human promyelocytic leukemia cell line (16) and U-937 is a monocytic cell line derived from a patient with histiocytic lymphoma (19 The publication costs of this article were defrayed in part by page charge payment. This article must 'therefore be hereby marked "advertisement" in accordance.with 18 U. S C. §1734 solely to indicate' this fact. complement, using a two-step cytotoxicity assay as described (7) . All four steps of purification were necessary for complete elimination of contaminating monocytes as evaluated by the absence of proliferative response in the presence of mitogens.
Monocyte Preparation. Monocytes were prepared by using their adherence-property on plastic culture flasks as described by others (21 A and the myeloid antigen My-i, but the.y increased the reactivity of K562 cells with the antiplatelet monoclonal antibody J2. These inducers thus appear to commit K562 cells along the megakaryocytic lineage. Hemin had a different effect; it enhanced hemoglobin accumulation-without a significant modification of the expression of other erythroid markers and slightly increased myeloid markers without modification of megakaryocytic ones. Thus, hemin appeared to cause K562 cells to commit to hemoglobin synthesis rather than to exert an actual differentiating role. Neither before nor after treatment with any differentiation inducer did K562 exhibit monocytic markers such as reactivity with OKM1 or Mo2 monoclonal antibody.
K562 cells did not react with any of the anti-HLA-DR monoclonal antibody tested, either before or after treatment with differentiation inducers. Similarly, no HLA-DR could be found on HL-60 cells. These results confirmed previously reported data (22) . HLA-DR antigens were expressed on about 10% of untreated and on about 50% of PMA-treated U-937 cells.
Accessory Activity of U-937 Cells. The capacity of the histiocytic U-937 cells to replace monocytes for mitogen-induced T-cell proliferation was first investigated. It can be seen in Table 1 that T cells purified by the four-step protocol described above were nearly unresponsive to both PHA and Con A, whereas monocyte addition elicited a marked T cell proliferative response in the presence of these lectins. U-937 cells appeared to be practically devoid of monocyte-replacing properties in this assay (Table 1) . However, PMA-treatment induced the appearance of clear accessory properties in U-937 cells, which became as efficient as monocytes in our proliferative assay. These data show that the AF of U-937 is strongly increased by cell differentiation along the monocytic lineage.
Accessory Activity of HL-60 Cells. It can be seen in Table  2 that noninduced promyelocytic HL-60 cells were devoid of any monocyte-replacing activity in the T-cell proliferative assay. Strikingly, both Me2SO and PMA treatments, though committing HL-60 in distinct pathways, elicited the appearance of a strong accessory activity, because Me2SO-treated as well as PMA-treated HL-60 cells induced strong T-cell proliferative responses after mitogen stimulations (Table 2) . Thus whereas the AF of HL-60 cells was clearly dependent upon their differentiation stage, their cellular commitment to either the granulocytic or the monocytic lineage did not play any apparent role in this function.
Accessory Activity of K562 Cells. In contrast with U-937 and HL-60 cells, which did not have AF before differentiation in- duction, K562 cells exhibited strikingly high accessory activity before any treatment (Table 3) . Untreated K562 cells were as efficient as peripheral blood monocytes in eliciting purified Tcell response to mitogens. This capacity was not modified by hemin induction. By contrast, both sodium butyrate and PMA, which exerted clear differentiating action on K562 cells, drastically reduced their accessory activity. IL-1 Production by Cell Lines. It can be seen in Fig. 1 that after triggering of the cells with PMA, HL-60 and K562 cells could both produce IL-1, whereas no significant amount of the interleukin could be detected in U-937 cell supernatants.
DISCUSSION
Understanding of the mechanisms of T-cell activation by antigen or mitogen has made considerable progress in the past few years. T-cell proliferation is dependent upon the presence of interleukin 2 (IL-2) (30) produced by some T-cell subset (31, 32) . Two distinct signals are required for IL-2 production: (i) mitogen or antigen processed by some antigen-presenting cells and (ii) IL-1. The essential role of macrophages in both the antigen-processing event and IL-1 production has been emphasized (33). Our experiments indicate that several human leukemia cell lines can replace macrophages in a 72-hr mitogen-induced proliferation assay. AF for T-cell proliferation was clearly not the exclusive property of cells from the monocytic series. Indeed, the undifferentiated hematopoietic precursor K562 cells and the myeloid HL-60 cells driven along granulocytic lineage by Me2SO were excellent AC in this assay, being as efficient as either normal monocytes from peripheral blood or PMA-treated HL-60 and U-937 cells that exhibited monocytic markers. Furthermore, our data showed that in various hematopoietic cells, AF is restricted to a precise differentiation stage: U-937 and HL-60 cells acquired their AF after treatment with differentiation inducers. On the other hand, K562 cells, which were highly efficient as AC, lost this property when treated with either sodium butyrate or PMA, but not with hemin.
The mechanism of the AF exerted by these human leukemia cell lines was probably related to their ability to produce IL-1. The supernatants of PMA-triggered K562 and HL-60 cells demonstrated co-stimulating activity with PHA towards murine thymocytes. This assay is commonly considered as specific for IL-1 (9) . No IL-2 could be found in the same supernatants, added to cultures of the IL-2-dependent murine CTLL-2 cells (34) (data not shown). Furthermore, these supernatants were submitted to filtration through Ultrogel AcA 54 (LKB). The fraction containing the thymocyte-stimulating activity was identical to that obtained with supernatants of muramyl-dipeptide-triggered monocytes (35) . The corresponding molecular weight was around 20,000, as reported for IL-1 (36) (data not shown, to be reported elsewhere). In mice, the production of IL-1 by cultured epidermal cells (37) and keratinocyte cell lines (38) has been reported. It therefore appears that a variety of cells other than macrophages can actually produce IL-1.
The murine Ia and human HLA-DR molecules are known to be involved in cell-cell cooperation. Both antigen-and mitogen-induced activation of T cells has been shown to require the presence of HLA-DR+ (Ia+) AC in human and mouse systems (39, 40) . It was reported that IL-2 production by purified T cells could be achieved only when HLA-DR+ cells, such as monoProc. Natl. Acad. Sci. USA 80 (1983) cytes (41, 42) or B-lymphoma Daudi cells (43) , were added to the culture. However, we here present the evidence that some HLA-DR-cells, such as K562 and HL-60, can exert AF and produce IL-I. These results suggest that, if HLA-DR (Ia) molecules are actually required for antigen presentation to responding T cells by AC, they are not directly concerned with the induction of IL-1 production by these cells. It was previously reported that anti-HLA-DR antibodies inhibited antigeninduced T-cell responses (44) but did not affect T-cell proliferation induced by Con A (45). Our results thus confirmed that HLA-DR antigens on AC are not directly involved in the process of T-cell activation by mitogens.
The finding that human leukemia cell lines can exert AF and produce IL-1 at some stage of their differentiation can lead to new information in the understanding of these functions. Such leukemic lines could be useful sources of human IL-1 for biochemical characterization and gene cloning. We 
